Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 18, 2025, Embla Medical (EMBLA.CO) has a market cap of $1.71 billion USD. According to our data, Embla Medical is ranked No.4238 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 18, 2025 | $1.71 B |
-26.14%
|
| Dec 30, 2024 | $2.32 B |
29.69%
|
| Dec 29, 2023 | $1.79 B |
-18.18%
|
| Dec 30, 2022 | $2.19 B |
-20.69%
|
| Dec 30, 2021 | $2.76 B |
-12.69%
|
| Dec 30, 2020 | $3.16 B |
-6.97%
|
| Dec 30, 2019 | $3.40 B |
68.90%
|
| Dec 28, 2018 | $2.01 B |
17.42%
|
| Dec 29, 2017 | $1.71 B |
6.28%
|
| Dec 30, 2016 | $1.61 B |
6.65%
|
| Dec 30, 2015 | $1.51 B |
34.64%
|
| Dec 30, 2014 | $1.12 B |
69.96%
|
| Dec 30, 2013 | $0.66 B |
40.74%
|
| Dec 28, 2012 | $0.47 B |
-11.70%
|
| Dec 30, 2011 | $0.53 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
| Market Cap | = | EMBLA.CO Stock Price | * | EMBLA.CO Shares Outstanding |
| = | $4.02 | * | 0.43 B | |
| = | $1.71 B |